Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate "BioShield II" Hearing To Discuss Manufacturer Liability, Development Incentives

This article was originally published in The Pink Sheet Daily

Executive Summary

Joint Health-Judiciary Committee hearing Oct. 6 will review additional incentives for pharmaceutical and biotech firms to develop medical countermeasures for bioterrorism-related threats.

You may also be interested in...



BioShield II Patent Extensions Will Increase Drug Costs, GPhA Says

The Generic Pharmaceuticals Association supports the overall goals of the bill but claims product exclusivity extensions will needlessly inflate pharmaceutical costs. The association will testify before the Oct. 6 joint Senate Judiciary/Health Committee hearing.

BioShield II Patent Extensions Will Increase Drug Costs, GPhA Says

The Generic Pharmaceuticals Association supports the overall goals of the bill but claims product exclusivity extensions will needlessly inflate pharmaceutical costs. The association will testify before the Oct. 6 joint Senate Judiciary/Health Committee hearing.

Senate “BioShield II” Hearing Postponed

The Senate Health Committee will reschedule a hearing on the "Project BioShield II" legislation planned for Sept. 8

Topics

UsernamePublicRestriction

Register

LL1135489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel